Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

2019 international clinical practice guidelines for the treatment of venous thromboembolism - Authors' reply.

Douketis JD, Frere C, Farge D; International Thrombosis and Cancer Initiative members.

Lancet Oncol. 2019 Dec;20(12):e656. doi: 10.1016/S1470-2045(19)30750-8. No abstract available.

PMID:
31797782
2.

Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with Postthrombotic Syndrome.

Cervi A, Douketis JD.

Thromb Haemost. 2019 Dec;119(12):1897-1899. doi: 10.1055/s-0039-1700808. Epub 2019 Nov 8. No abstract available.

PMID:
31705519
3.

Structure and function of a perioperative anticoagulation management clinic.

Spencer NH, Sardo LA, Cordell JP, Douketis JD.

Thromb Res. 2019 Oct;182:167-174. doi: 10.1016/j.thromres.2019.08.007. Epub 2019 Aug 23.

PMID:
31494438
4.

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk.

Spyropoulos AC, Brohi K, Caprini J, Samama CM, Siegal D, Tafur A, Verhamme P, Douketis JD; SSC Subcommittee on Perioperative and Critical Care Thrombosis and Haemostasis of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2019 Nov;17(11):1966-1972. doi: 10.1111/jth.14598. Epub 2019 Aug 22. No abstract available.

PMID:
31436045
5.

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.

Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S.

JAMA Intern Med. 2019 Aug 5. doi: 10.1001/jamainternmed.2019.2431. [Epub ahead of print]

PMID:
31380891
6.

Pulmonary embolism: update on diagnosis and management.

Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ.

Med J Aust. 2019 Jul;211(2):82-87. doi: 10.5694/mja2.50233. Epub 2019 Jun 19. Review.

PMID:
31216072
7.

Deep vein thrombosis: update on diagnosis and management.

Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ.

Med J Aust. 2019 Jun;210(11):516-524. doi: 10.5694/mja2.50201. Epub 2019 Jun 2. Review.

PMID:
31155730
8.

Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.

Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA.

J Thromb Haemost. 2019 Jul;17(7):1144-1152. doi: 10.1111/jth.14458. Epub 2019 May 20.

PMID:
31033194
9.

An assay to measure levels of factor Xa inhibitors in blood and plasma.

Kim PY, Di Giuseppantonio LR, Wu C, Douketis JD, Gross PL.

J Thromb Haemost. 2019 Jul;17(7):1153-1159. doi: 10.1111/jth.14451. Epub 2019 May 10.

PMID:
30985986
10.

A Device on Trial - Intermittent Pneumatic Compression in Critical Care.

Lauzier F, Douketis JD, Cook DJ.

N Engl J Med. 2019 Apr 4;380(14):1367-1368. doi: 10.1056/NEJMe1902334. No abstract available.

PMID:
30943342
11.

Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.

Cervi A, Douketis JD.

Intern Emerg Med. 2019 Jun;14(4):495-496. doi: 10.1007/s11739-019-02078-4. Epub 2019 Apr 1. No abstract available.

PMID:
30937833
12.

Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly.

Riva N, Righini M, Camporese G, Iotti M, Bucherini E, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P, Ageno W; PALLADIO Study Investigators.

Thromb Res. 2019 Feb;174:148-150. doi: 10.1016/j.thromres.2018.12.024. Epub 2019 Jan 3. No abstract available.

PMID:
30634165
13.

Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach.

Douketis JD, Darvish-Kazem S, Spencer N, Tafur A.

Pol Arch Intern Med. 2018 Dec 21;128(12):771-778. doi: 10.20452/pamw.4403. Epub 2018 Dec 21. Review. Erratum in: Pol Arch Intern Med. 2019 Jan 31;129(1):72.

14.

Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time.

Dubé C, Douketis JD, Moffat KA, Schulman S, Blais N.

Thromb Res. 2018 Nov;171:62-67. doi: 10.1016/j.thromres.2018.09.051. Epub 2018 Sep 19.

PMID:
30261356
15.

Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale.

Douketis JD, Spyropoulos AC, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M, Dentali F, Duncan J, Gross PL, Kassis J, Kowalski S, Lee AY, Gal GL, Templier GL, Li N, MacKay E, Shah V, Shivakumar S, Solymoss S, Spencer FA, Syed S, Tafur AJ, Vanassche T, Thiele T, Wu C, Yeo E, Schulman S.

Thromb Haemost. 2018 Sep;118(9):1679-1680. doi: 10.1055/s-0038-1668582. Epub 2018 Sep 14. No abstract available.

PMID:
30216954
16.

A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?

Douketis JD, Radwi M.

Intern Emerg Med. 2018 Oct;13(7):997-999. doi: 10.1007/s11739-018-1930-y. Epub 2018 Aug 24. No abstract available.

PMID:
30143965
17.

Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery.

Tseng EK, Kolesar E, Handa P, Douketis JD, Anvari M, Tiboni M, Crowther MA, Siegal DM.

J Thromb Haemost. 2018 Oct;16(10):2008-2015. doi: 10.1111/jth.14263. Epub 2018 Aug 31.

PMID:
30099852
18.

Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016-2017.

Cervi A, Douketis JD.

Intern Emerg Med. 2019 Apr;14(3):355-363. doi: 10.1007/s11739-018-1910-2. Epub 2018 Jul 27. Review.

PMID:
30054799
19.

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.

Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandão da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ; PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators.

PLoS One. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285. eCollection 2018.

20.

Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial.

Douketis JD, Murphy SA, Antman EM, Grip LT, Mercuri MF, Ruff CT, Weitz JI, Braunwald E, Giugliano RP.

Thromb Haemost. 2018 Jun;118(6):1001-1008. doi: 10.1055/s-0038-1645856. Epub 2018 May 3.

PMID:
29723874
21.

Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Diendéré G, Piché A, Filion KB, Klil-Drori AJ, Douketis JD, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3. Review.

22.

A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Leblanc K, Semchuk WM, Papastergiou J, Snow B, Mandlsohn L, Kapoor V, Guirguis LM, Douketis JD, Geerts W, Gladstone DJ.

Can Pharm J (Ott). 2018 Feb 9;151(2):102-106. doi: 10.1177/1715163518756926. eCollection 2018 Mar-Apr. No abstract available.

23.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Bhagirath V, Liaw PC, Weitz JI, Julian JA.

Blood. 2018 May 10;131(19):2151-2160. doi: 10.1182/blood-2017-09-805689. Epub 2018 Feb 28.

24.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel.

Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19. Review.

PMID:
29475527
25.

Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial.

Clark NP, Douketis JD, Hasselblad V, Schulman S, Kindzelski AL, Ortel TL; BRIDGE Investigators.

Am Heart J. 2018 Jan;195:108-114. doi: 10.1016/j.ahj.2017.09.015. Epub 2017 Sep 21.

26.

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.

Douketis JD, Spyropoulos AC, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M, Dentali F, Duncan J, Gross PL, Kassis J, Kowalski S, Lee AY, Le Gal G, Le Templier G, Li N, MacKay E, Shah V, Shivakumar S, Solymoss S, Spencer FA, Syed S, Tafur AJ, Vanassche T, Thiele T, Wu C, Yeo E, Schulman S.

Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6. Erratum in: Thromb Haemost. 2018 Sep;118(9):1679-1680.

PMID:
29212129
27.

Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm.

Riva N, Camporese G, Iotti M, Bucherini E, Righini M, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P, Ageno W; PALLADIO Study Investigators.

J Thromb Haemost. 2018 Feb;16(2):271-278. doi: 10.1111/jth.13905. Epub 2017 Dec 8.

PMID:
29125695
28.

Navigating the anticoagulant landscape in 2017.

Douketis JD.

Cleve Clin J Med. 2017 Oct;84(10):768-778. doi: 10.3949/ccjm.84gr.17005. Review.

29.

Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials.

Liew AY, Piran S, Eikelboom JW, Douketis JD.

J Thromb Thrombolysis. 2017 Apr;43(3):291-301. doi: 10.1007/s11239-016-1461-1. Review.

PMID:
27900627
30.

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment.

Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD.

J Thromb Haemost. 2016 Dec;14(12):2556-2559. doi: 10.1111/jth.13505. Epub 2016 Oct 24. No abstract available.

31.

The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.

Douketis JD.

Intern Emerg Med. 2016 Dec;11(8):1031-1035. Epub 2016 Oct 20. Review.

PMID:
27766542
32.

Bridge Therapy Outcomes in Patients With Mechanical Heart Valves.

Delate T, Meisinger SM, Witt DM, Jenkins D, Douketis JD, Clark NP.

Clin Appl Thromb Hemost. 2017 Nov;23(8):1036-1041. doi: 10.1177/1076029616669786. Epub 2016 Sep 21.

PMID:
27655997
33.

Perioperative Management of the Direct Oral Anticoagulants: A Case-Based Review.

Bell BR, Spyropoulos AC, Douketis JD.

Hematol Oncol Clin North Am. 2016 Oct;30(5):1073-84. doi: 10.1016/j.hoc.2016.05.005. Review.

PMID:
27637308
34.

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Liaw PC, Weitz JI, Julian JA.

Thromb Res. 2016 Oct;146:119-125. doi: 10.1016/j.thromres.2016.06.023. Epub 2016 Jun 23.

PMID:
27354153
35.

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.

Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD.

J Thromb Haemost. 2016 May;14(5):875-85. doi: 10.1111/jth.13305. Epub 2016 Apr 7. Review.

36.

Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF.

Barnes GD, Douketis JD.

Ann Intern Med. 2016 Mar 15;164(6):JC33. doi: 10.7326/ACPJC-2016-164-6-033. No abstract available.

PMID:
26974733
37.

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial.

Douketis JD, Healey JS, Brueckmann M, Fraessdorf M, Spyropoulos AC, Wallentin L, Oldgren J, Reilly P, Ezekowitz MD, Connolly SJ, Yusuf S, Eikelboom JW.

Thromb Res. 2016 Mar;139:77-81. doi: 10.1016/j.thromres.2016.01.004. Epub 2016 Jan 9.

PMID:
26916299
38.

Periprocedural Management of Direct Oral Anticoagulants: Comment on the 2015 American Society of Regional Anesthesia and Pain Medicine Guidelines.

Douketis JD, Syed S, Schulman S.

Reg Anesth Pain Med. 2016 Mar-Apr;41(2):127-9. doi: 10.1097/AAP.0000000000000360. Review. No abstract available.

PMID:
26882272
39.

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD.

J Thromb Thrombolysis. 2016 Jan;41(1):154-64. doi: 10.1007/s11239-015-1316-1. Review.

40.

Bridging Anticoagulation in Patients with Atrial Fibrillation.

Douketis JD, Hasselblad V, Ortel TL.

N Engl J Med. 2016 Jan 7;374(1):93-4. doi: 10.1056/NEJMc1513255. No abstract available.

PMID:
26736004
41.

Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.

Bates SM, Takach Lapner S, Douketis JD, Kearon C, Julian J, Parpia S, Schulman S, Weitz JI, Linkins LA, Crowther M, Lim W, Spencer FA, Lee AY, Gross PL, Ginsberg J.

J Thromb Haemost. 2016 Mar;14(3):504-9. doi: 10.1111/jth.13234. Epub 2016 Feb 5.

42.

Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study.

Ageno W, Camporese G, Riva N, Iotti M, Bucherini E, Righini M, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P; PALLADIO Study Investigators.

Lancet Haematol. 2015 Nov;2(11):e474-80. doi: 10.1016/S2352-3026(15)00190-8. Epub 2015 Oct 18.

PMID:
26686257
43.

Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure.

Douketis JD, Wang G, Chan N, Eikelboom JW, Syed S, Barty R, Moffat KA, Spencer FA, Blostein M, Schulman S.

J Thromb Haemost. 2016 Jan;14(1):89-97. doi: 10.1111/jth.13178. Epub 2016 Jan 4.

44.
45.

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE Investigators.

N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.

46.

Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.

Clark NP, Witt DM, Davies LE, Saito EM, McCool KH, Douketis JD, Metz KR, Delate T.

JAMA Intern Med. 2015 Jul;175(7):1163-8. doi: 10.1001/jamainternmed.2015.1843.

PMID:
26010033
47.

Perioperative Management of Dabigatran: A Prospective Cohort Study.

Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M, Spencer FA, Solymoss S, Barty R, Wang G, Heddle N, Douketis JD; Periop Dabigatran Study Group.

Circulation. 2015 Jul 21;132(3):167-73. doi: 10.1161/CIRCULATIONAHA.115.015688. Epub 2015 May 12.

PMID:
25966905
48.

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.

Marcucci M, Iorio A, Douketis JD, Eichinger S, Tosetto A, Baglin T, Cushman M, Palareti G, Poli D, Tait RC, Kyrle PA.

J Thromb Haemost. 2015 May;13(5):775-81. doi: 10.1111/jth.12871. Epub 2015 Mar 12.

49.

Anticoagulation therapy: Perioperative anticoagulation-are we at 'a bridge too far'?

Douketis JD.

Nat Rev Cardiol. 2015 Mar;12(3):133-4. doi: 10.1038/nrcardio.2015.7. Epub 2015 Feb 3.

PMID:
25645499
50.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA; D-dimer Optimal Duration Study Investigators.

Ann Intern Med. 2015 Jan 6;162(1):27-34. doi: 10.7326/M14-1275.

PMID:
25560712

Supplemental Content

Loading ...
Support Center